article thumbnail

A trial HIV vaccine triggered elusive and essential antibodies in humans

Science Daily: Pharmacology News

An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

Vaccine 337
article thumbnail

More Americans are using psilocybin -- especially those with mental health conditions, study shows

Science Daily: Pharmacology News

Use of psilocybin, the hallucinogenic chemical found in what is known as 'magic mushrooms,' has increased significantly nationwide since 2019, according to a new study.

288
288
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genetic tracing at the Huanan Seafood market further supports COVID animal origins

Science Daily: Pharmacology News

A new study provides a list of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose in late 2019. The study is based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).

Marketing 338
article thumbnail

Why petting your cat leads to static electricity

Science Daily: Pharmacology News

In 2019, researchers discovered nanosized surface deformations at play. Static electricity was first observed in 600 B.C., but researchers have struggled to explain how rubbing causes it. The same researchers now say different electrical charges build up on the front and back parts of a sliding object, creating a current.

Research 309
article thumbnail

Flagship-backed Generate raises $273M as its first drugs move to the clinic

BioPharma Drive: Drug Pricing

Since 2019, Generate has raised nearly $700 million in private financing and has now brought a monoclonal antibody into Phase 1 testing.

Drugs 313
article thumbnail

Pfizer to pull sickle cell drug from market, shut down trials

BioPharma Drive: Drug Pricing

The withdrawal comes as trial results indicate safety concerns with the drug, Oxbryta, which was first approved in the U.S.

Trials 280
article thumbnail

Forest carbon storage has declined across much of the Western U.S., likely due to drought and fire

Science Daily: Pharmacology News

The paper analyzed trends in carbon storage across the American West from 2005 to 2019. But a new study confirms widespread doubts about the potential for most forests in the Western US to help curb climate change.

303
303